Tag archive for ‘Arthritis Drug’
Ilan Shavit On Wednesday, December 16th, 2015

Kitov Pharma’s arthritis drug meets main goal in late-stage study

Israel-based Kitov Pharmaceuticals Holdings Ltd said on Tuesday its lead drug met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA), reducing More...

Gil Tanenbaum On Tuesday, December 30th, 2014

Israel’s Can-Fite BioPharma Moves Forward with Rheumatoid Arthritis Drug

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, has completed the Design of the Rheumatoid Arthritis More...

Jewish Business News On Thursday, April 17th, 2014

Teva Settles Patent Litigation with Pfizer on arthritis treatment Celebrex

– Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its subsidiary Teva Pharmaceuticals USA, Inc. has More...

Moshe Golan On Thursday, March 13th, 2014

Court Gives Teva Green Light For Generic Arthritis Drug

– A federal judge in Virginia ruled that the patent for Pfizer’s Celebrex expires in May. – A US federal judge in Virginia has given Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) More...

Wordpress site Developed by Fixing WordPress Problems